Table 3.
Group | N | Prevalence (95% CI)1 | POR2(95% CI) | POR3(95% CI) | POR4(95% CI) |
---|---|---|---|---|---|
Total |
1496 |
31.0 (28.8, 33.3) |
|
||
Men |
616 |
34.1 (30.5, 37.9) |
1.3 (1.1,1.6) |
1.5 (1.1, 1.9) |
2.1 (1.6, 3.0) |
Women |
880 |
27.9 (25.0, 30.6) |
1.0 |
1.0 |
1.0 |
Blacks |
419 |
31.0 (26.7, 35.7) |
1.0 (0.8,1.3) |
1.2 (0.9, 1.6) |
1.2 (0.9, 1.6) |
Whites |
1077 |
31.0 (28.4, 33.8) |
1.0 |
1.0 |
1.0 |
Men |
|
|
|
|
|
Blacks |
160 |
30.9 (24.1, 38.7) |
0.8 (0.5,1.2) |
0.9 (0.6, 1.5) |
0.9 (0.6, 1.5) |
Whites |
454 |
35.3 (31.0, 39.8) |
1.0 |
1.0 |
1.0 |
Women |
|
|
|
|
|
Blacks |
259 |
31.0 (25.8, 36.7) |
1.2 (0.9,1.7) |
1.5 (1.1, 2.3) |
1.7 (1.1, 2.5) |
Whites | 621 | 26.6 (23.6, 29.9) | 1.0 | 1.0 | 1.0 |
1 SBP ≥ 140 mmHg or DBP ≥ 90 mmHg or currently taking antihypertensive medication.
2 Crude Prevalence Odds Ratio.
3 Age-Adjusted Prevalence Odds Ratio.
4 Prevalence Odds Ratio adjusted for age, education, BMI, waist circumference, alcohol intake, and exercise.